A detailed history of Liberty One Investment Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Liberty One Investment Management, LLC holds 154 shares of TGTX stock, worth $4,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154
Previous 993 84.49%
Holding current value
$4,952
Previous $18,000 83.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$17.21 - $25.28 $14,439 - $21,209
-839 Reduced 84.49%
154 $3,000
Q2 2024

Jul 22, 2024

SELL
$13.32 - $19.19 $772 - $1,113
-58 Reduced 5.52%
993 $18,000
Q1 2024

Apr 30, 2024

SELL
$13.02 - $21.3 $924 - $1,512
-71 Reduced 6.33%
1,051 $15,000
Q4 2023

Jan 26, 2024

BUY
$6.68 - $18.81 $3,887 - $10,947
582 Added 107.78%
1,122 $19,000
Q3 2023

Nov 03, 2023

BUY
$8.36 - $26.5 $526 - $1,669
63 Added 13.21%
540 $4,000
Q1 2023

May 15, 2023

BUY
$10.23 - $19.34 $3,611 - $6,827
353 Added 284.68%
477 $7,000
Q3 2022

Nov 16, 2022

SELL
$4.57 - $8.4 $20,953 - $38,514
-4,585 Reduced 97.37%
124 $1,000
Q2 2022

Aug 01, 2022

BUY
$3.74 - $10.66 $17,147 - $48,876
4,585 Added 3697.58%
4,709 $183,000
Q1 2022

May 03, 2022

BUY
$7.81 - $20.45 $968 - $2,535
124 New
124 $1,000
Q4 2021

Jan 21, 2022

SELL
$15.2 - $35.51 $71,394 - $166,790
-4,697 Closed
0 $0
Q3 2021

Oct 20, 2021

SELL
$21.78 - $40.45 $261 - $485
-12 Reduced 0.25%
4,697 $156,000
Q2 2021

Jul 20, 2021

BUY
$32.5 - $48.96 $36,920 - $55,618
1,136 Added 31.79%
4,709 $183,000
Q1 2021

Apr 06, 2021

SELL
$41.61 - $54.3 $2,787 - $3,638
-67 Reduced 1.84%
3,573 $172,000
Q4 2020

Jan 20, 2021

SELL
$25.27 - $54.9 $1,415 - $3,074
-56 Reduced 1.52%
3,640 $189,000
Q3 2020

Nov 03, 2020

BUY
$18.49 - $27.24 $26,459 - $38,980
1,431 Added 63.18%
3,696 $99,000
Q2 2020

Jul 22, 2020

BUY
$8.9 - $21.84 $20,158 - $49,467
2,265 New
2,265 $44,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.67B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Liberty One Investment Management, LLC Portfolio

Follow Liberty One Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty One Investment Management, LLC with notifications on news.